Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001104659-25-078716·EAGLE PHARMACEUTICALS, INC.
Schedule 13G ownership disclosure
EAGLE PHARMACEUTICALS INC
Common stock, $0.001 par value per share · CUSIP: 269796108
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Nantahala Capital Management, LLC
Shares: 4,945,209.00 · Class: 38.08%
- Wilmot B. Harkey
Shares: 4,945,209.00 · Class: 38.08%
- Daniel Mack
Shares: 4,945,209.00 · Class: 38.08%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-078716
- Form type
- SCHEDULE 13G/A
- Filer
- EAGLE PHARMACEUTICALS, INC.
- CIK
- CIK 827871
- Filed
- Aug 14, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership